For the current REF see the REF 2021 website REF 2021 logo

Output details

2 - Public Health, Health Services and Primary Care

University College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

A phase 3 trial of bevacizumab in ovarian cancer.

Type
D - Journal article
Title of journal
N Engl J Med
Article number
-
Volume number
365
Issue number
26
First page of article
2484
ISSN of journal
1533-4406
Year of publication
2011
Number of additional authors
26
Additional information

The author made a substantial contribution to the conception and design of the study, the organisation of the conduct of the study, and the analysis and interpretation of study data. The author helped draft the output.

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
218
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-